OBIO icon

Orchestra BioMed
OBIO

Overview Fund Activity

53 hedge funds and large institutions have $129M invested in Orchestra BioMed in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
53
Holders Change
+5
Holders Change %
+10.42%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
11
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
D.E. Shaw & Co
1
D.E. Shaw & Co
New York
$7.79M
2
WAM
2
Weiss Asset Management
Massachusetts
$2.96M
3
KKRC
3
Kohlberg Kravis Roberts & Co
New York
$1.7M
4
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$1.48M
5
HI
5
HBK Investments
Texas
$620K

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$1.13M
2
IC
2
Ikarian Capital
Texas
$0
3
AC
3
Athanor Capital
New York
$0
4
BFM
4
Boothbay Fund Management
New York
$1.67M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$7.99M
Name Market Value Shares Shares
Change 		Shares
Change %
LWA
51
Lenox Wealth Advisors
New York
$20K 2,000 +2,000 New
Morgan Stanley
52
Morgan Stanley
New York
$7K 657 – –
TRCT
53
Tower Research Capital (TRC)
New York
$2K 197 +50 +34%
IC
54
Ikarian Capital
Texas
– – -197,173 Closed
AC
55
Athanor Capital
New York
– – -21,757 Closed
HI
56
Harbour Investments
Wisconsin
– – -3,000 Closed
UBS Group
57
UBS Group
Switzerland
– – -537 Closed
CFGS
58
Concourse Financial Group Securities
Alabama
– – – –
1 2
3